Abbott Laboratories (ABT, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs. Abbott Laboratories has a market cap of $154.65 billion; its shares were traded at around $87.45 with a P/E ratio of 42.45 and P/S ratio of 4.96. The dividend yield of Abbott Laboratories stocks is 1.51%. Abbott Laboratories had annual average EBITDA growth of 7.90% over the past five years. GuruFocus has detected 2 severe warning signs with Abbott Laboratories. .
For the last quarter Abbott Laboratories reported a revenue of $8.3 billion, compared with the revenue of $7.8 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $31.9 billion, an increase of 4.3% from last year. For the complete 30-year financial data, please go here.. For the last five years Abbott Laboratories had an average revenue growth rate of 11.3% a year.
The reported diluted earnings per share was $2.06 for the year, an increase of 54.9% from previous year. Over the last five years Abbott Laboratories had an average EPS decline of 5.5% a year. The Abbott Laboratories had a decent operating margin of 14.21%, compared with the operating margin of 11.94% a year before. The 10-year historical median operating margin of Abbott Laboratories is 12.39%. The profitability rank of the company is 8 (out of 10).
At the current stock price of $87.45, Abbott Laboratories is traded at 62.7% premium to its historical median P/S valuation band of $53.75. The P/S ratio of the stock is 4.96, while the historical median P/S ratio is 3.05. The stock gained 18.14% during the past 12 months.
CFO Recent Trades:
- Executive Vice President & CFO Brian B Yoor sold 509,850 shares of ABT stock on 01/28/2020 at the average price of $89.73. The price of the stock has decreased by 2.54% since.
Directors and Officers Recent Trades:
- Executive Vice President Mary K Moreland sold 1,019 shares of ABT stock on 02/19/2020 at the average price of $88.97. The price of the stock has decreased by 1.71% since.
- Senior Vice President Michael D Dale sold 396 shares of ABT stock on 02/19/2020 at the average price of $88.97. The price of the stock has decreased by 1.71% since.
- Executive Vice President Andrea F Wainer sold 1,120 shares of ABT stock on 02/07/2020 at the average price of $88.61. The price of the stock has decreased by 1.31% since.
- Senior Vice President Joseph J Manning sold 37,500 shares of ABT stock on 01/27/2020 at the average price of $89.58. The price of the stock has decreased by 2.38% since.
For the complete 20-year historical financial data of ABT, click here.
